Improving quality of care in vascular surgery: The tools are available now

American Journal of Surgery

Volumn 190, Issue 2, 2005, Pages 333-337

  Henke, Peter K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Atherosclerosis; Deep vein thrombosis; Preoperative evaluation; Quality of care

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ARTERY BYPASS; ATHEROSCLEROSIS; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; HEALTH CARE QUALITY; HEART INFARCTION; HUMAN; PATIENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STROKE; VASCULAR SURGERY;

EID: 22044450373     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.05.036     Document Type: Article

References (48)

1. H.J. Barnett, D.W. Taylor, M. Eliasziw North American Symptomatic Carotid Endarterectomy Trial Collaborators Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis N Engl J Med 339 1998 1415 1425
2. North American Symptomatic Carotid Endarterectomy Trial Collaborators Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis N Engl J Med 325 1991 445 453
3. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study Endarterectomy for asymptomatic carotid artery stenosis JAMA 273 1995 1421 1428
4. F.A. Lederle, S.E. Wilson, G.R. Johnson Immediate repair compared with surveillance of small abdominal aortic aneurysms N Engl J Med 346 2002 1437 1444
5. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial participants Lancet 352 1998 1649 1655
6. R.M. Greenhalgh, L.C. Brown, G.P. Kwong Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1) 30-day operative mortality results randomised controlled trial Lancet 364 2004 843 848
7. M. Prinssen, E.L. Verhoeven, J. Buth A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms N Engl J Med 351 2004 1607 1618
8. D. Mukherjee, K.A. Eagle Perioperative cardiac assessment for noncardiac surgery eight steps to the best possible outcome Circulation 107 2003 2771 2774
9. S.C. Smith Jr, S.N. Blair, R.O. Bonow AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 104 2001 1577 1579
10. N.R. Hertzer, E.G. Beven, J.R. Young Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management Ann Surg 199 1984 223 233
11. E.O. McFalls, H.B. Ward, T.E. Moritz Coronary-artery revascularization before elective major vascular surgery N Engl J Med 351 2004 2795 2804
12. D. Poldermans, E. Boersma, J.J. Bax Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery N Engl J Med 341 1999 1789 1794
13. D.T. Mangano Aspirin and mortality from coronary bypass surgery N Engl J Med 347 2002 1309 1317
14. T.F. Kresowik, R.A. Hemann, S.L. Grund Improving the outcomes of carotid endarterectomy results of a statewide quality improvement project J Vasc Surg 31 2000 918 926
15. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
16. J.M. Gaspoz, P.G. Coxson, P.A. Goldman Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease N Engl J Med 346 2002 1800 1806
17. S.M. Grundy, J.I. Cleeman, C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Arterioscler Thromb Vasc Biol 24 2004 149 161
18. A.W. Chan, D.L. Bhatt, D.P. Chew Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention Circulation 105 2002 691 696
19. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals. A randomised placebo-controlled trial Lancet 360 2002 7 22
20. C. Heeschen, C.W. Hamm, U. Laufs Withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation 105 2002 1446 1452
21. P.K. Henke, S. Blackburn, M.C. Proctor Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications effect on graft patency, limb salvage, and mortality J Vasc Surg 39 2004 357 365
22. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
23. National Kidney Foundation-Dialysis Outcomes Quality Initiative NKF-DOQI clinical practice guidelines for vascular access Am J Kidney Dis 30 1997 S150 S191
24. P. Klinkert, A. Schepers, D.H. Burger Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting five-year results of a randomized controlled trial J Vasc Surg 37 2003 149 155
25. W.C. Johnson, K.K. Lee A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization a prospective randomized Department of Veterans Affairs cooperative study J Vasc Surg 32 2000 268 277
26. M.R. Jackson, T.P. Belott, T. Dickason The consequences of a failed femoropopliteal bypass grafting comparison of saphenous vein and PTFE grafts J Vasc Surg 32 2000 498 505
27. P.K. Henke, M.C. Proctor, P.J. Zajkowski Tissue loss, early primary graft occlusion, female gender, and a prohibitive failure rate of secondary infrainguinal arterial reconstruction J Vasc Surg 35 2002 902 909
28. T.M. Bergamini, S.M.J. George, H.T. Massey Intensive surveillance of femoropopliteal-tibial autogenous vein bypass improves long-term graft patency and limb salvage Ann Surg 221 1995 507 516
29. D.F. Bandyk Essentials of graft surveillance Semin Vasc Surg 6 1993 92 102
30. K. Kasirajan, P.A. Schneider Early outcome of "cutting" balloon for infrainguinal vein graft stenosis J Vasc Surg 2004 702 708
31. S.Z. Goldhaber, A.G. Turpie Prevention of venous thromboembolism among hospitalized medical patients Circulation 111 2005 1 3
32. S.Z. Goldhaber, V.F. Tapson A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis Am J Cardiol 93 2004 259 262
33. W.H. Geerts, G.F. Pineo, J.A. Heit Prevention of venous thromboembolism the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 338S 400S
34. M.M. Samama, A.T. Cohen, J.Y. Darmon Prophylaxis in Medical Patients With Enoxaparin Study Group A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients N Engl J Med 341 1999 793 800
35. A. Leizorovicz, A.T. Cohen, A.G. Turpie Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 2004 874 879
36. A.T. Cohen, A.S. Gallus, M.R. Lassen Fondaparinux vs. placebo for the prevention of venous thromboembolism in acutely ill medical patients J Thromb Haemost 1 2003 2090 2096
37. R. Hull, T. Delmore, E. Genton Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis N Engl J Med 301 1979 855 858
38. A.J. Comerota Quality-of-life improvement using thrombolytic therapy for iliofemoral deep venous thrombosis Rev Cardiovasc Med 3 suppl 2 2002 S61 S67
39. D.P. Brandjes, H.R. Buller, H. Heijboer Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis Lancet 349 1997 759 762
40. L.J. Greenfield, M.C. Proctor Recurrent thromboembolism in patients with vena cava filters J Vasc Surg 33 2001 510 514
41. M.D. Cabana, C.S. Rand, N.R. Powe Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1999 1458 1465
42. J.M. Grimshaw, I.T. Russell Effect of clinical guidelines on medical practice a systematic review of rigorous evaluations Lancet 342 1993 1317 1322
43. D. Mukherjee, J. Fang, S. Chetcuti Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes Circulation 109 2004 745 749
44. R. Tooher, P. Middleton, C. Pham A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals Ann Surg 241 2005 397 415
45. J.G. Kral, J.B. Dixon, F.F. Horber Flaws in methods of evidence-based medicine may adversely affect public health directives Surgery 137 2005 279 284
46. P.M. Rothwell External validity of randomised controlled trials To whom do the results of this trial apply? Lancet 365 2005 82 93
47. M.A. Hlatky Underuse of evidence-based therapies Circulation 110 2004 644 645
48. E.H. Shively, M.J. Heine, R.H. Schell Practicing surgeons lead in quality care, safety, and cost control Ann Surg 239 2004 752 762